Richard Anderson UK

Professor Richard A Anderson MD, PhD, FRCOG, FRCPE first became involved in research in reproductive biology when undertaking an intercalated PhD as a medical student in the UK's Medical Research Council (MRC) Brain Metabolism Unit, on the role of the amino acid neurotransmitter gamma-aminobutyric acid (GABA) in the hypothalamus and pituitary gland. Thereafter, he trained in obstetrics and gynaecology in Edinburgh, undertaking a two-year World Health Organisation (WHO) research fellowship in hormonal male contraception under the supervision of Fred Wu, at the MRC Reproductive Biology Unit. Then, he completed his training in reproductive medicine as a lecturer at the University of Edinburgh with David Baird, continuing research work in contraceptive development locally and in collaboration with colleagues in Nigeria, South Africa and Hong Kong. After a year as a Travelling Fellow in the laboratory of Professor Sam Yen at University of California San Diego, he returned to a Consultant post at the MRC Research Biology Unit and at the Royal Infirmary of Edinburgh, with clinical work in infertility and reproductive endocrinology. He took up his present post as Professor of Clinical Reproductive Science at the University of Edinburgh in 2005, and has subsequently become head of the University Section of Obstetrics and Gynaecology. Over these years he established a research group focused mainly on the female reproductive lifespan, with laboratory work identifying mechanisms of development in the fetal ovary, and developing clinical research largely related to fertility preservation, with a particular interest in individualising the assessment of risk to fertility. This culminated in the first UK birth following ovarian tissue cryopreservation and transplantation. His current research activity is predominantly in both clinical and laboratory studies in ovarian development and function after cancer, and in male contraception, continuing his links to WHO and to the National Institute of Child Health and Human Development (NICHD) in the US. Over the last decade, he has also been involved in the physiology and the development of clinical applications of the novel neuropeptides kisspeptin and neurokinin B. First-in-man studies with kisspeptin 10 demonstrated that this neuropeptide increased GnRH pulse frequency in normal men. More recent work using a neurokinin B antagonist has revealed physiological roles in both men and women, as well as potential therapeutic application in polycystic ovary syndrome (PCOS) and for menopausal hot flushes. He has published over 250 papers and has an H index of 66. He has chaired the Royal College of Obstetricians and Gynaecologists (RCOG) Scientific Advisory Committee, and previously been a member of both that Committee and the Guidelines and Audit Committee. He has also been involved in RCOG working parties, producing reports on the reproductive effects of cancer treatment (jointly with the other UK Royal Colleges), and in fetal awareness. More recently, he was a member of the European Society of Human Reproduction and Embryology (ESHRE) Guideline Group on Premature Ovarian Insufficiency, he has contributed to guidelines produced by the Scottish Intercollegiate Guideline Network, and currently chairs a Scottish Government committee for the establishment of fertility preservation services. He is the founder coordinator of the new ESHRE Special Interest Group (SIG) in Fertility Preservation, and has previously been a deputy coordinator for the SIG in Reproductive Endocrinology. He has been a Visiting Professor in Adelaide, Copenhagen and Melbourne and continues active collaborations with colleagues in those cities and elsewhere. He has served as an Associate Editor for three of the ESHRE human reproduction journals, for the Journal of Clinical Endocrinology and Metabolism, and for the Journal of Assisted Reproduction and Genetics. He is looking forward to the new challenges of being an Editor for RBM Online and seeing it develop further as a high choice journal for clinicians and scientists in reproductive medicine. Together with the rest of the Editorial team he hopes to contribute to make RBM Online a stand-out journal for novel and high-quality research in the field.